Brain activation and connectivity after 2–3 weeks of escitalopram administration in anxiety disorders: A randomised trial焦虑障碍患者服用艾司西酞普兰2-3周后的脑激活与连接:一项随机试验Journal of Affective DisordersIF4.92025-11-130OAAI
Approach-avoidance reinforcement learning as a translational and computational model of anxiety-related avoidanceELIFEIF02023-11-143OAAI
Longitudinal decline in striatal dopamine transporter binding in Parkinson's disease: associations with apathy and anhedoniaJOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRYIF7.52023-05-239OAAI
Computational perspectives on human fear and anxietyNEUROSCIENCE AND BIOBEHAVIORAL REVIEWSIF7.92023-01-017OAAI
The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging studyPSYCHOPHARMACOLOGYIF3.32022-04-2112OAAI
Effects of cannabidiol (CBD) alone and combined with Δ9-tetrahydrocannabinol (THC) on functional connectivity of the pain-matrixEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-12-010PRE
How representative are neuroimaging samples? Large-scale evidence for trait anxiety differences between fMRI and behaviour-only research participantsSOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCEIF3.12021-05-0527OAAI
The acute effects of cannabidiol on emotional processing and anxiety: A neurocognitive imaging studyEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-01-010PREAI
The acute effects of cannabidiol on reward processing in humans: an fMRI studyEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-01-010PREAI
The effects of cannabidiol on cerebral blood flow and its relationship to memory: an arterial spin labelling studyEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-01-010PREAI